We are live on
!
Find out more
Pacira BioSciences
PCRX
PCRX
260 hedge funds and large institutions have $1.21B invested in Pacira BioSciences in 2025 Q4 according to their latest regulatory filings, with 49 funds opening new positions, 87 increasing their positions, 92 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
293% more call options, than puts
Call options by funds: $2.5M | Put options by funds: $638K
96% more first-time investments, than exits
New positions opened: 49 | Existing positions closed: 25
9% more funds holding
Funds holding: 239 → 260 (+21)
2.35% more ownership
Funds ownership: 106.76% → 109.11% (+2.4%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
2% less capital invested
Capital invested by funds: $1.24B → $1.21B (-$21.3M)
5% less repeat investments, than reductions
Existing positions increased: 87 | Existing positions reduced: 92
Holders
260
Holders Change
+21
Holders Change %
+8.79%
% of All Funds
3.16%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
49
Increased
87
Reduced
92
Closed
25
Calls
$2.5M
Puts
$638K
Net Calls
+$1.87M
Net Calls Change
-$602K
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$17.8M |
| 2 |
HIM
Hillsdale Investment Management
Toronto,
Ontario, Canada
|
+$7.33M |
| 3 |
Jane Street
New York
|
+$5.69M |
| 4 |
Two Sigma Investments
New York
|
+$5.2M |
| 5 |
LSV Asset Management
Chicago,
Illinois
|
+$4.89M |
Top Sellers
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
-$22.3M |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$11.5M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$10.6M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$9.15M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$7.04M |
